AIM2 and neoplasm: Furthermore, the AIM2 inflammasome elicits immunosuppression following antibody-dependent cell phagocytosis (ADCP) and tumor cell DNA sensing, by upregulating PD-L1 and IDO expression, which inhibit anti-tumor immunity by NK and T cells (Su et al., 2018).